ATRI Atrion Corp: רווח למניה ב-12 החודשים האחרונים

Atrion Corporation (ATRI) relies on stable demand in defensive medicine, which eliminates business seasonality. However, geopolitical disruptions in raw material supplies could increase costs and limit exports. This chart of relative EPS YoY TTM illustrates the earnings per share trend, where the value -37.50 represents the most recent figure. The company's success is based on the demand for anesthesia components while maintaining a healthy operating margin.
פילוחי מדדים פיננסיים ומדדי שוק עבור Atrion Corporation Inc. (ATRI)

Atrion Corporation (ATRI) owns vertically integrated medical technology manufacturing facilities in the US, ensuring the stability of its operational processes. Analyzing the comparable annual growth of EPS TTM allows an investor to view the efficiency of this model through the lens of net income. This metric is calculated as the percentage change in earnings per share over the last twelve months relative to the previous year. This price action reflects the pace of business capitalization and its competitiveness within the sector. The steady ascent of the line confirms the fundamental attractiveness of the asset.